Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ACI Formulations's Total Assets for the quarter that ended in Mar. 2026 was BDT9,362 Mil.
Warning Sign:
If a company builds assets at 9.7% a year, faster than its revenue growth rate of 8.8% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, ACI Formulations's average Total Assets Growth Rate was 11.80% per year.
During the past 3 years, the average Total Assets Growth Rate was 10.10% per year.
During the past 5 years, the average Total Assets Growth Rate was 9.70% per year.
During the past 10 years, the average Total Assets Growth Rate was 7.90% per year.
During the past 13 years, ACI Formulations's highest 3-Year average Total Assets Growth Rate was 23.20%. The lowest was -0.80%. And the median was 10.10%.
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
ACI Formulations's Asset Turnover for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
ACI Formulations Total Assets Related Terms
ACI Formulations Total Assets Historical Data
* Premium members only.
The historical data trend for ACI Formulations's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
ACI Formulations's Total Assets for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ACI Formulations (DHA:ACIFORMULA) has a Total Assets of BDT9,362 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on ACI Formulations and its competitors.
Is ACI Formulations' Total Assets too high?
ACI Formulations' current Total Assets is BDT9,362 Mil. Overall, ACI Formulations has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ACI Formulations' Total Assets compare to CTVA and CF?
ACI Formulations' Total Assets of BDT9,362 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for an Agriculture company?
A good Total Assets depends on the Agriculture industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on ACI Formulations and its competitors. ACI Formulations's current Total Assets is BDT9,362 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACI Formulations stock overvalued right now?
Based on GuruFocus' analysis, ACI Formulations (DHA:ACIFORMULA) is currently considered Modestly Overvalued. The stock's GF Value™ is BDT149.48, compared to a current price of BDT172.00 — trading 15.1% above its estimated fair value. The current Total Assets is BDT9,362 Mil. ACI Formulations' overall GF Score™ is 88/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For ACI Formulations (DHA:ACIFORMULA), the current Total Assets is BDT9,362 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ACI Formulations (DHA:ACIFORMULA) Overvalued in 2026?
Based on GuruFocus' analysis, ACI Formulations stock appears to be overvalued.
The current stock price of BDT172.00 is trading 15.1% above its estimated GF Value™ of BDT149.48.
GuruFocus considers ACI Formulations to be Modestly Overvalued.
Key valuation signals for DHA:ACIFORMULA:
Total Assets: BDT9,362 Mil
GF Value™: BDT149.48 vs. price of BDT172.00 (15.1% above fair value)
No single metric tells the full story. See the DHA:ACIFORMULA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ACI Formulations PLC is engaged in the manufacturing and marketing of several agrochemical and consumer products. The company offers a complete range of cost-effective solutions for farmers through formulating and marketing insecticides, herbicides, fungicides, miticides, etc. Its businesses are Pharmaceuticals, Salt, Skincare & Antiseptics, Kitchen Care, Fabric Care, Surface Care, Herbal Care, Lavatory Care, and Others. The group's reportable segments are Crop Care and Public Health (CC & PH), which include manufacturing and selling crop care and public health products; Mosquito coil (M. Coil) includes manufacturing and selling mosquito coil products; Aerosol provides manufacturing and selling aerosol and air freshener products; and Paint covers manufacture and sell paint products.
88GF Score
Get the complete analysis for DHA:ACIFORMULA
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:ACIFORMULA has been successfully added to your 
